Biomerica Inc. (BMRA)
NASDAQ: BMRA
· Real-Time Price · USD
2.86
-0.02 (-0.69%)
At close: Oct 15, 2025, 3:59 PM
2.86
0.00%
After-hours: Oct 15, 2025, 06:54 PM EDT
Biomerica Income Statement
Financials in USD. Fiscal
year is
June - May.
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Period Ending | May 31, 2025 | May 31, 2024 | May 31, 2023 | May 31, 2022 | May 31, 2021 |
Revenue | 5.31M | 5.42M | 5.34M | 18.87M | 7.2M |
Cost of Revenue | 4.81M | 4.8M | 4.89M | 15.89M | 6.7M |
Gross Profit | 498K | 611K | 446K | 2.98M | 496.98K |
Operating Income | -5.14M | -6.37M | -7.22M | -4.53M | -6.52M |
Interest Income | 165K | 431K | 133K | 27K | 66.86K |
Pretax Income | -4.97M | -5.94M | -7.09M | -4.51M | -6.46M |
Net Income | -4.97M | -5.98M | -7.14M | -4.53M | -6.47M |
Selling & General & Admin | 4.61M | 5.49M | 6.08M | 5.7M | 4.61M |
Research & Development | 1.02M | 1.49M | 1.58M | 1.81M | 2.41M |
Other Expenses | n/a | n/a | 1K | n/a | n/a |
Operating Expenses | 5.63M | 6.98M | 7.67M | 7.51M | 7.02M |
Interest Expense | n/a | n/a | n/a | n/a | 367.00 |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 10.45M | 11.78M | 12.56M | 23.41M | 13.72M |
Income Tax Expense | 1K | 42K | 51K | 23.72K | 13.06K |
Shares Outstanding (Basic) | 2.3M | 16.82M | 14.15M | 12.67M | 11.93M |
Shares Outstanding (Diluted) | 2.3M | 16.82M | 14.15M | 12.67M | 11.93M |
EPS (Basic) | -2.16 | -0.36 | -0.5 | -0.36 | -0.54 |
EPS (Diluted) | -2.16 | -0.36 | -0.5 | -0.36 | -0.54 |
EBITDA | -4.74M | -5.99M | -6.74M | -3.94M | -7.06M |
EBIT | -5.14M | -6.37M | -7.22M | -4.53M | -7.43M |
Depreciation & Amortization | 400K | 374K | 351K | 594.82K | 375.86K |
Source: Financial Modeling Prep. Financial Sources.